측방유동 어세이 시장 : 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Lateral Flow Assay Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 7,411,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,823,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,604,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 세계 측방유동 어세이 시장에 대한 종합적인 분석을 발표하여 성장 요인, 과제 및 새로운 동향에 대한 심층적인 통찰력을 제공합니다. 이 상세한 보고서는 2024년부터 2031년까지 시장 발전을 예측하는 독점 데이터와 통계를 제공합니다.

주요 인사이트

• 측방유동 어세이 시장 규모(2024E) : 91억 달러
• 예상 시장 가치(2031F) : 124억 달러
• 세계 시장 성장률(2024-2031년 CAGR) : 4.50%.

측방유동 어세이 시장 : 조사 범위

래터럴 플로우 어세이는 신속 진단법으로서 헬스케어, 식품 안전, 동물 진단, 환경 검사 등 다양한 산업에서 매우 중요한 역할을 하고 있습니다. 측방유동 어세이은 간편성, 신속성, 비용 효율성으로 인해 현장 검사, 재택 진단, 현장 검진에 광범위하게 적용되고 있습니다.

세계 측방유동 어세이 시장은 전염병 증가, 신속한 진단 솔루션에 대한 수요 증가, 분석 기술의 발전 등의 요인으로 인해 크게 성장하고 있습니다. 또한, 식품 안전 및 환경 모니터링과 같은 헬스케어 분야 외에도 측방유동 어세이의 응용 분야가 확대되고 있는 점도 시장 성장을 더욱 촉진하고 있습니다.

시장 성장의 촉진요인:

전 세계적으로 감염성 질환의 발병률 증가와 신속하고 정확한 진단 솔루션에 대한 필요성이 헬스케어 분야에서 측방유동 어세이에 대한 수요를 주도하고 있습니다. 또한, 측방유동 어세이 플랫폼의 기술 발전으로 민감도, 특이성, 다중화 기능이 향상되어 다양한 응용 분야에서 유용성이 증가하고 있습니다. 또한, 식품 안전과 환경 모니터링의 중요성에 대한 인식이 높아짐에 따라 이러한 분야에서 측방유동 어세이에 대한 수요가 증가하여 시장 성장에 기여하고 있습니다.

시장 성장 억제요인 :

세계 측방유동 어세이 시장은 큰 성장 잠재력에도 불구하고, 기존 분석의 민감도 및 특이도가 제한적이어서 위양성 및 위음성 결과를 초래하는 등 여러 가지 문제에 직면해 있습니다. 이러한 한계를 극복하기 위해서는 분석 구성 요소의 지속적인 혁신과 최적화가 필요하며, 이는 기술적, 규제적 장애물이 될 수 있습니다.

또한, 측방유동 어세이 시장의 경쟁 환경은 유사한 제품을 제공하는 다수의 기업이 존재하여 가격 경쟁과 마진 압박이 심화되고 있습니다. 또한, 제품 검증 및 승인에 대한 엄격한 규제 요건은 특히 신규 시장 진출기업 및 소규모 제조업체 시장 진입을 복잡하게 만들고 있습니다.

시장 기회 :

마이크로플루이드, 디지털 이미징, 스마트폰 기반 검출의 통합과 같은 분석 기술의 발전은 측방유동 어세이 분야의 기술 혁신과 시장 확대의 기회로 작용하고 있습니다. 또한, 신흥 경제국에서는 의료비 증가, 의료 인프라 개선, 감염성 질환에 대한 인식이 높아지면서 측방유동 어세이의 채택이 증가하고 있어 큰 성장 잠재력을 가지고 있습니다. 또한, 진단 기업, 연구 기관, 정부 기관간의 제휴 및 협력 관계는 미개척 지역에서의 기술 이전, 역량 개발 및 시장 진입을 촉진합니다.

본 보고서에서 다룬 주요 질문들

• 측방유동 어세이 시장의 성장을 주도하는 부문와 응용 분야는 무엇인가?
• 측방유동 어세이의 미래를 좌우할 주요 기술 발전과 혁신은 무엇인가?
• 규제 프레임워크와 상환 정책이 시장 역학 및 경쟁에 어떤 영향을 미치는가?
• 시장 지배력과 경쟁 우위를 유지하기 위한 주요 기업와 그 전략은 무엇인가?
• 세계 측방유동 어세이 시장의 새로운 트렌드와 미래 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/ 분류
• 시장의 정의/ 범위/ 제한

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 중요 성공 요인

• 제품 채택/사용 상황 분석
• 제품 USP/특징
• 주요 프로모션 전략
• 규제 시나리오
• PESTLE 분석
• Porter의 Five Forces 분석
• 지역역학
• 최근 제품 발매와 승인

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 세계의 측방유동 어세이 시장 - COVID-19 위기-영향 평가

• 현재 통계와 향후 영향 가능성
• COVID-19의 영향
• 부문별 영향 분석

제7장 세계의 측방유동 어세이 시장 - 가격 분석

• 제품 유형별 지역별 가격 분석
• 세계 평균 가격 분석 벤치마크

제8장 세계의 측방유동 어세이 시장(수량) 분석

• 과거 시장 규모(수량) 분석, 2012-2023년
• 현재 및 향후 시장 규모(수량) 예측, 2024-2031년
  • 전년대비 성장 동향 분석

제9장 세계의 측방유동 어세이 시장(금액 및 규모) 분석

• 과거 시장 매출(금액) 분석, 2012-2023년
• 현재 및 향후 시장 매출(금액) 예측, 2024-2031년
  • 전년대비 성장 동향 분석
  • 절대적 매출 기회 분석

제10장 세계의 측방유동 어세이 시장 분석, 제품 유형별

• 서론/주요 조사 결과
• 과거 시장 규모(금액)와 수량 분석, 2012-2023년
• 현재 및 향후 시장 규모(금액)와 수량 분석·예측, 2024-2031년
  • 리더
    • 벤치탑 리더
    • 핸드헬드 리더
  • LFA 키트
    • 테스트 스트립
    • 딥 스틱
    • 카세트
    • 란셋
• 제품 유형별 시장의 매력 분석

제11장 세계의 측방유동 어세이 시장 분석, 용도별

• 서론/주요 조사 결과
• 과거 시장 규모(금액)와 수량 분석, 2012-2023년
• 현재 및 향후 시장 규모(금액)와 수량 분석·예측, 2024-2031년
  • 성감염증
    • 인간 결손 바이러스(HIV) 감염증
    • 임질
    • 매독
    • 기타
  • 감염증
    • 모기 매개성 질환
    • 연쇄구균 감염증
    • 간염 감염
    • 위장 감염증
    • 호흡기 감염증
    • 기타
  • 당뇨병
  • 임신 및 생식 능력 검사
  • 약물 남용 검사
• 용도별 시장의 매력 분석

제12장 세계의 측방유동 어세이 시장 분석, 유통 채널별

• 서론/주요 조사 결과
• 과거 시장 규모(금액)와 수량 분석, 2012-2023년
• 현재 및 향후 시장 규모(금액)와 수량 분석·예측, 2024-2031년
  • 병원 약국
  • 소매 약국
  • 슈퍼마켓/하이퍼마켓
  • E-Commerce
• 용도별 시장의 매력 분석

제13장 측방유동 어세이 시장 분석, 지역별

• 서론
• 과거 시장 규모(금액)와 수량 분석, 2012-2023년
• 현재 및 향후 시장 규모(금액)와 수량 분석·예측, 2024-2031년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 지역별 시장의 매력 분석

제14장 북미의 측방유동 어세이 시장 분석

제15장 라틴아메리카의 측방유동 어세이 시장 분석

제16장 유럽의 측방유동 어세이 시장 분석

제17장 남아시아의 측방유동 어세이 시장 분석

제18장 동아시아의 측방유동 어세이 시장 분석

제19장 오세아니아의 측방유동 어세이 시장 분석

제20장 중동 및 아프리카의 측방유동 어세이 시장 분석

제21장 시장 구조 분석

• 기업 Tier별 시장 분석(측방유동 어세이)
• 주요 기업의 시장 점유율 분석

제22장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁 상세
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Becton, Dickinson &Company
  • PerkinElmer Inc.
  • Siemens Healthineers
  • QIAGEN NV
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Maternova Inc.
  • Quidel Corporation
  • Healgen Scientific, LLC.
  • Meridian Bioscience Inc.
  • Abcam plc.
  • Access Bio, Inc.
  • Humasis Co. Ltd.
  • DIALUNOX GmbH
  • Detekt Biomedical LLC
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Creative Diagnostics

제23장 사용된 전제조건과 두자어

제24장 조사 방법

LSH

영문 목차

영문목차

Persistence Market Research unveils a comprehensive analysis of the global lateral flow assay market, providing deep insights into its growth trajectory, challenges, and emerging trends. This detailed report offers exclusive data and statistics forecasting the market's progression from 2024 to 2031.

Key Insights:

• Lateral Flow Assay Market Size (2024E): US$ 9.1 Billion
• Projected Market Value (2031F): US$ 12.4 Billion
• Global Market Growth Rate (CAGR 2024 to 2031): 4.50%

Lateral Flow Assay Market - Report Scope:

Lateral flow assay, a rapid diagnostic method, plays a pivotal role in various industries, including healthcare, food safety, veterinary diagnostics, and environmental testing. Utilizing its simplicity, speed, and cost-effectiveness, lateral flow assays find extensive application in point-of-care testing, home diagnostics, and on-site screening.

The global lateral flow assay market experiences substantial growth driven by factors such as the increasing prevalence of infectious diseases, the rising demand for rapid diagnostic solutions, and advancements in assay technologies. Moreover, the expanding applications of lateral flow assays beyond healthcare, such as in food safety and environmental monitoring, further propel market growth.

Market Growth Drivers:

The escalating incidence of infectious diseases worldwide, coupled with the need for rapid and accurate diagnostic solutions, drives the demand for lateral flow assays in the healthcare sector. With the emergence of novel pathogens and the persistence of endemic diseases, there is a growing emphasis on early detection and prompt intervention, fueling the adoption of lateral flow assays.Furthermore, technological advancements in lateral flow assay platforms enhance their sensitivity, specificity, and multiplexing capabilities, widening their utility across diverse applications. Additionally, the increasing awareness regarding the importance of food safety and environmental monitoring drives the demand for lateral flow assays in these sectors, contributing to market growth.

Market Restraints:

Despite the significant growth prospects, the global lateral flow assay market faces challenges such as the limited sensitivity and specificity of conventional assays, leading to false-positive or false-negative results. Addressing these limitations requires continuous innovation and optimization of assay components, which may pose technical and regulatory hurdles.

Moreover, the competitive landscape of the lateral flow assay market is characterized by the presence of numerous players offering similar products, intensifying price competition and margin pressures. Additionally, stringent regulatory requirements for product validation and approval add complexity to market entry, particularly for new entrants and small-scale manufacturers.

Market Opportunities:

The ongoing advancements in assay technologies, including the integration of microfluidics, digital imaging, and smartphone-based detection, present lucrative opportunities for innovation and market expansion in the lateral flow assay segment. These developments enable enhanced sensitivity, quantitative analysis, and connectivity, catering to the evolving needs of end-users across various industries.Furthermore, the increasing adoption of lateral flow assays in emerging economies, driven by rising healthcare expenditure, improving healthcare infrastructure, and growing awareness about infectious diseases, offers significant growth potential. Additionally, partnerships and collaborations between diagnostic companies, research institutions, and government agencies facilitate technology transfer, capacity building, and market access in untapped regions.

Key Questions Answered in the Report:

• Which segments and applications are driving the growth of the lateral flow assay market?
• What are the key technological advancements and innovations shaping the future of lateral flow assays?
• How do regulatory frameworks and reimbursement policies influence market dynamics and competition?
• Who are the leading players and what are their strategies to maintain market dominance and competitiveness?
• What are the emerging trends and future prospects in the global lateral flow assay market?

Competitive Intelligence and Business Strategy:

To stay ahead in the competitive landscape, key players in the lateral flow assay market focus on product innovation, strategic partnerships, and geographic expansion. Companies such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, and Danaher Corporation invest in research and development to launch next-generation lateral flow assay platforms with improved performance and usability. Moreover, strategic collaborations with healthcare providers, distribution partners, and regulatory agencies enable companies to penetrate new markets, enhance customer reach, and navigate regulatory challenges effectively. In summary, a combination of innovation, collaboration, and market diversification strategies ensures sustained growth and competitiveness in the dynamic lateral flow assay market.

Key Companies Profiled:

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Siemens Healthineers AG
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Merck KGaA
• PerkinElmer, Inc.

Lateral Flow Assay Market Research Segmentation:

Lateral Flow Assay Market by Product Type:

• LFA Readers
• Benchtop Readers
• Handheld Readers
• LFA Kits
• Test Strips
• Dipsticks
• Cassettes
• Lancets

Lateral Flow Assay Market by Application:

• Sexually Transmitted Diseases
• Human Deficiency Virus (HIV) Infection
• Gonorrhoea
• Syphilis
• Others
• Infectious Diseases
• Mosquito-Borne Diseases
• Streptococcus Infections
• Hepatitis Infection
• Gastrointestinal Infections
• Respiratory Tract Infections
• Others
• Diabetes
• Pregnancy and Fertility Testing
• Drug of Abuse Testing

Lateral Flow Assay Market by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Supermarkets/Hypermarkets
• e-Commerce

Lateral Flow Assay Market by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmap
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Key Promotional Strategies
• 4.4. Regulatory Scenario
• 4.5. PESTLE Analysis
• 4.6. Porter's Analysis
• 4.7. Regional Epidemiology
• 4.8. Recent Product Launches and Approvals

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Increasing Spending on Healthcare Per Capita
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. Growing Usage of Home-based Lateral Flow Assay Devices
  • 5.2.3. Increasing Global Prevalence of Acute and Chronic Infectious Diseases
  • 5.2.4. Rising Geriatric Population
  • 5.2.5. Entry of Domestic Players into the Market
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. Global Lateral Flow Assay Market- COVID-19 Crisis - Impact Assessment

• 6.1. Current Statistics and Probable Future Impact
• 6.2. Impact of COVID-19
• 6.3. Impact Analysis, By segment

7. Global Lateral Flow Assay Market - Pricing Analysis

• 7.1. Regional Pricing Analysis By Product Type
• 7.2. Global Average Pricing Analysis Benchmark

8. Global Lateral Flow Assay Market Volume (in 000 Units) Analysis 2012-2023 and Forecast, 2024-2031

• 8.1. Historical Market Volume (in 000 Units) Analysis, 2012-2023
• 8.2. Current and Future Market Volume (in 000 Units) Projections, 2024-2031
  • 8.2.1. Y-o-Y Growth Trend Analysis

9. Global Lateral Flow Assay Market (in Value or Size in US$ Mn) Analysis 2012-2023 and Forecast, 2024-2031

• 9.1. Historical Market Value (US$ Mn) Analysis, 2012-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Product Type

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2031
  • 10.3.1. Readers
    • 10.3.1.1. Bench-Top Readers
    • 10.3.1.2. Hand-held Readers
  • 10.3.2. LFA Kits
    • 10.3.2.1. Test Strips
    • 10.3.2.2. Dipsticks
    • 10.3.2.3. Cassettes
    • 10.3.2.4. Lancets
• 10.4. Market Attractiveness Analysis By Product Type

11. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Application

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
  • 11.3.1. Sexually Transmitted Diseases
    • 11.3.1.1. Human Deficiency Virus (HIV) Infection
    • 11.3.1.2. Gonorrhoea
    • 11.3.1.3. Syphilis
    • 11.3.1.4. Others
  • 11.3.2. Infectious Diseases
    • 11.3.2.1. Mosquito-Borne Diseases
    • 11.3.2.2. Streptococcus Infections
    • 11.3.2.3. Hepatitis Infection
    • 11.3.2.4. Gastrointestinal Infections
    • 11.3.2.5. Respiratory Tract Infections
    • 11.3.2.6. Others
  • 11.3.3. Diabetes
  • 11.3.4. Pregnancy and Fertility Testing
  • 11.3.5. Drug of Abuse Testing
• 11.4. Market Attractiveness Analysis By Application

12. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Distribution Channel

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
  • 12.3.1. Hospital Pharmacies
  • 12.3.2. Retail Pharmacies
  • 12.3.3. Supermarket/Hypermarket
  • 12.3.4. E-Commerce
• 12.4. Market Attractiveness Analysis By Application

13. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2023
• 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (MEA)
• 13.4. Market Attractiveness Analysis By Region

14. North America Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 14.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product Type
  • 14.3.3. By Application
  • 14.3.4. By Distribution Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product Type
  • 14.4.3. By Application
  • 14.4.4. By Distribution Channel
• 14.5. Country Level Analysis & Forecast
  • 14.5.1. U.S. Lateral Flow Assay Analysis
    • 14.5.1.1. Introduction
    • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.1.2.1. By Product Type
      • 14.5.1.2.2. By Application
      • 14.5.1.2.3. By Distribution Channel
  • 14.5.2. Canada Lateral Flow Assay Analysis
    • 14.5.2.1. Introduction
    • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.2.2.1. By Product Type
      • 14.5.2.2.2. By Application
      • 14.5.2.2.3. By Distribution Channel
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis

15. Latin America Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 15.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 15.3.1. By Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Mexico
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product Type
  • 15.3.3. By Application
  • 15.3.4. By Distribution Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product Type
  • 15.4.3. By Application
  • 15.4.4. By Distribution Channel
• 15.5. Country Level Analysis & Forecast
  • 15.5.1. Brazil Lateral Flow Assay Analysis
    • 15.5.1.1. .Introduction
    • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.1.2.1. By Product Type
      • 15.5.1.2.2. By Application
      • 15.5.1.2.3. By Distribution Channel
  • 15.5.2. Mexico Lateral Flow Assay Analysis
    • 15.5.2.1. Introduction
    • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.2.2.1. By Product Type
      • 15.5.2.2.2. By Application
      • 15.5.2.2.3. By Distribution Channel
  • 15.5.3. Argentina Lateral Flow Assay Analysis
    • 15.5.3.1. Introduction
    • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.3.2.1. By Product Type
      • 15.5.3.2.2. By Application
      • 15.5.3.2.3. By Distribution Channel
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis

16. Europe Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 16.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. France
    • 16.3.1.3. Italy
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. Russia
    • 16.3.1.7. Nordic Countries
    • 16.3.1.8. BENELUX
    • 16.3.1.9. Rest of Europe
  • 16.3.2. By Product Type
  • 16.3.3. By Application
  • 16.3.4. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product Type
  • 16.4.3. By Application
  • 16.4.4. By Distribution Channel
• 16.5. Country Level Analysis & Forecast
  • 16.5.1. Germany Lateral Flow Assay Analysis
    • 16.5.1.1. .Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Product Type
      • 16.5.1.2.2. By Application
      • 16.5.1.2.3. By Distribution Channel
  • 16.5.2. France Lateral Flow Assay Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Product Type
      • 16.5.2.2.2. By Application
      • 16.5.2.2.3. By Distribution Channel
  • 16.5.3. Italy Lateral Flow Assay Analysis
    • 16.5.3.1. Introduction
    • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.3.2.1. By Product Type
      • 16.5.3.2.2. By Application
      • 16.5.3.2.3. By Distribution Channel
  • 16.5.4. U.K. Lateral Flow Assay Analysis
    • 16.5.4.1. .Introduction
    • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.4.2.1. By Product Type
      • 16.5.4.2.2. By Application
      • 16.5.4.2.3. By Distribution Channel
  • 16.5.5. Spain Lateral Flow Assay Analysis
    • 16.5.5.1. .Introduction
    • 16.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.5.2.1. By Product Type
      • 16.5.5.2.2. By Application
      • 16.5.5.2.3. By Distribution Channel
  • 16.5.6. Russia Lateral Flow Assay Analysis
    • 16.5.6.1. .Introduction
    • 16.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.6.2.1. By Product Type
      • 16.5.6.2.2. By Application
      • 16.5.6.2.3. By Distribution Channel
  • 16.5.7. Nordic Countries Lateral Flow Assay Analysis
    • 16.5.7.1. .Introduction
    • 16.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.7.2.1. By Product Type
      • 16.5.7.2.2. By Application
      • 16.5.7.2.3. By Distribution Channel
  • 16.5.8. BENELUX Lateral Flow Assay Analysis
    • 16.5.8.1. .Introduction
    • 16.5.8.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.8.2.1. By Product Type
      • 16.5.8.2.2. By Application
      • 16.5.8.2.3. By Distribution Channel
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis

17. South Asia Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 17.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Philippines
    • 17.3.1.5. Thailand
    • 17.3.1.6. Vietnam
    • 17.3.1.7. Rest of South Asia
  • 17.3.2. By Product Type
  • 17.3.3. By Application
  • 17.3.4. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product Type
  • 17.4.3. By Application
  • 17.4.4. By Distribution Channel
• 17.5. Country Level Analysis & Forecast
  • 17.5.1. India Lateral Flow Assay Analysis
    • 17.5.1.1. .Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Product Type
      • 17.5.1.2.2. By Application
      • 17.5.1.2.3. By Distribution Channel
  • 17.5.2. Indonesia Lateral Flow Assay Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Product Type
      • 17.5.2.2.2. By Application
      • 17.5.2.2.3. By Distribution Channel
  • 17.5.3. Malaysia Lateral Flow Assay Analysis
    • 17.5.3.1. Introduction
    • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.3.2.1. By Product Type
      • 17.5.3.2.2. By Application
      • 17.5.3.2.3. By Distribution Channel
  • 17.5.4. Philippines Lateral Flow Assay Analysis
    • 17.5.4.1. .Introduction
    • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.4.2.1. By Product Type
      • 17.5.4.2.2. By Application
      • 17.5.4.2.3. By Distribution Channel
  • 17.5.5. Thailand Lateral Flow Assay Analysis
    • 17.5.5.1. .Introduction
    • 17.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.5.2.1. By Product Type
      • 17.5.5.2.2. By Application
      • 17.5.5.2.3. By Distribution Channel
  • 17.5.6. Vietnam Lateral Flow Assay Analysis
    • 17.5.6.1. .Introduction
    • 17.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.6.2.1. By Product Type
      • 17.5.6.2.2. By Application
      • 17.5.6.2.3. By Distribution Channel
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis

18. East Asia Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 18.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Product Type
  • 18.3.3. By Application
  • 18.3.4. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product Type
  • 18.4.3. By Application
  • 18.4.4. By Distribution Channel
• 18.5. Country Level Analysis & Forecast
  • 18.5.1. China Lateral Flow Assay Analysis
    • 18.5.1.1. .Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Product Type
      • 18.5.1.2.2. By Application
      • 18.5.1.2.3. By Distribution Channel
  • 18.5.2. Japan Lateral Flow Assay Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Product Type
      • 18.5.2.2.2. By Application
      • 18.5.2.2.3. By Distribution Channel
  • 18.5.3. South Korea Lateral Flow Assay Analysis
    • 18.5.3.1. Introduction
    • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.3.2.1. By Product Type
      • 18.5.3.2.2. By Application
      • 18.5.3.2.3. By Distribution Channel
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis

19. Oceania Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 19.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product Type
  • 19.3.3. By Application
  • 19.3.4. By Distribution Channel
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product Type
  • 19.4.3. By Application
  • 19.4.4. By Distribution Channel
• 19.5. Country Level Analysis & Forecast
  • 19.5.1. Australia Lateral Flow Assay Analysis
    • 19.5.1.1. .Introduction
    • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.1.2.1. By Product Type
      • 19.5.1.2.2. By Application
      • 19.5.1.2.3. By Distribution Channel
  • 19.5.2. New Zealand Lateral Flow Assay Analysis
    • 19.5.2.1. Introduction
    • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.2.2.1. By Product Type
      • 19.5.2.2.2. By Application
      • 19.5.2.2.3. By Distribution Channel
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
• 20.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
  • 20.3.1. By Country
    • 20.3.1.1. Turkey
    • 20.3.1.2. GCC Countries
    • 20.3.1.3. Northern Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product Type
  • 20.3.3. By Application
  • 20.3.4. By Distribution Channel
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product Type
  • 20.4.3. By Application
  • 20.4.4. By Distribution Channel
• 20.5. Country Level Analysis & Forecast
  • 20.5.1. Turkey Lateral Flow Assay Analysis
    • 20.5.1.1. Introduction
    • 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.1.2.1. By Product Type
      • 20.5.1.2.2. By Application
      • 20.5.1.2.3. By Distribution Channel
  • 20.5.2. GCC Countries Lateral Flow Assay Analysis
    • 20.5.2.1. Introduction
    • 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.2.2.1. By Product Type
      • 20.5.2.2.2. By Application
      • 20.5.2.2.3. By Distribution Channel
  • 20.5.3. Northern Africa Lateral Flow Assay Analysis
    • 20.5.3.1. Introduction
    • 20.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.3.2.1. By Product Type
      • 20.5.3.2.2. By Application
      • 20.5.3.2.3. By Distribution Channel
  • 20.5.4. South Africa Lateral Flow Assay Analysis
    • 20.5.4.1. Introduction
    • 20.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.4.2.1. By Product Type
      • 20.5.4.2.2. By Application
      • 20.5.4.2.3. By Distribution Channel
• 20.6. Key Market Participants - Intensity Mapping
• 20.7. Drivers and Restraints - Impact Analysis

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies (Lateral Flow Assay)
• 21.2. Market Share Analysis of Top Players

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Thermo Fisher Scientific Inc.
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Sales Footprint
    • 22.3.1.4. Strategy Overview
    • 22.3.1.5. Key Financials
    • 22.3.1.6. SWOT analysis
  • 22.3.2. F. Hoffmann-La Roche
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Sales Footprint
    • 22.3.2.4. Strategy Overview
    • 22.3.2.5. Key Financials
    • 22.3.2.6. SWOT analysis
  • 22.3.3. Abbott Laboratories
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Sales Footprint
    • 22.3.3.4. Strategy Overview
    • 22.3.3.5. Key Financials
    • 22.3.3.6. SWOT analysis
  • 22.3.4. Becton, Dickinson & Company
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Sales Footprint
    • 22.3.4.4. Strategy Overview
    • 22.3.4.5. Key Financials
    • 22.3.4.6. SWOT analysis
  • 22.3.5. PerkinElmer Inc.
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Sales Footprint
    • 22.3.5.4. Strategy Overview
    • 22.3.5.5. Key Financials
    • 22.3.5.6. SWOT analysis
  • 22.3.6. Siemens Healthineers
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Sales Footprint
    • 22.3.6.4. Strategy Overview
    • 22.3.6.5. Key Financials
    • 22.3.6.6. SWOT analysis
  • 22.3.7. QIAGEN N.V.
    • 22.3.7.1. Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Sales Footprint
    • 22.3.7.4. Strategy Overview
    • 22.3.7.5. Key Financials
    • 22.3.7.6. SWOT analysis
  • 22.3.8. bioMerieux SA
    • 22.3.8.1. Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Sales Footprint
    • 22.3.8.4. Strategy Overview
    • 22.3.8.5. Key Financials
    • 22.3.8.6. SWOT analysis
  • 22.3.9. Bio-Rad Laboratories, Inc.
    • 22.3.9.1. Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Sales Footprint
    • 22.3.9.4. Strategy Overview
    • 22.3.9.5. Key Financials
    • 22.3.9.6. SWOT analysis
  • 22.3.10. Maternova Inc.
    • 22.3.10.1. Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Sales Footprint
    • 22.3.10.4. Strategy Overview
    • 22.3.10.5. Key Financials
    • 22.3.10.6. SWOT analysis
  • 22.3.11. Quidel Corporation
    • 22.3.11.1. Overview
    • 22.3.11.2. Product Portfolio
    • 22.3.11.3. Sales Footprint
    • 22.3.11.4. Strategy Overview
    • 22.3.11.5. Key Financials
    • 22.3.11.6. SWOT analysis
  • 22.3.12. Healgen Scientific, LLC.
    • 22.3.12.1. Overview
    • 22.3.12.2. Product Portfolio
    • 22.3.12.3. Sales Footprint
    • 22.3.12.4. Strategy Overview
    • 22.3.12.5. Key Financials
    • 22.3.12.6. SWOT analysis
  • 22.3.13. Meridian Bioscience Inc.
    • 22.3.13.1. Overview
    • 22.3.13.2. Product Portfolio
    • 22.3.13.3. Sales Footprint
    • 22.3.13.4. Strategy Overview
    • 22.3.13.5. Key Financials
    • 22.3.13.6. SWOT analysis
  • 22.3.14. Abcam plc.
    • 22.3.14.1. Overview
    • 22.3.14.2. Product Portfolio
    • 22.3.14.3. Sales Footprint
    • 22.3.14.4. Strategy Overview
    • 22.3.14.5. Key Financials
    • 22.3.14.6. SWOT analysis
  • 22.3.15. Access Bio, Inc.
    • 22.3.15.1. Overview
    • 22.3.15.2. Product Portfolio
    • 22.3.15.3. Sales Footprint
    • 22.3.15.4. Strategy Overview
    • 22.3.15.5. Key Financials
    • 22.3.15.6. SWOT analysis
  • 22.3.16. Humasis Co. Ltd.
    • 22.3.16.1. Overview
    • 22.3.16.2. Product Portfolio
    • 22.3.16.3. Sales Footprint
    • 22.3.16.4. Strategy Overview
    • 22.3.16.5. Key Financials
    • 22.3.16.6. SWOT analysis
  • 22.3.17. DIALUNOX GmbH
    • 22.3.17.1. Overview
    • 22.3.17.2. Product Portfolio
    • 22.3.17.3. Sales Footprint
    • 22.3.17.4. Strategy Overview
    • 22.3.17.5. Key Financials
    • 22.3.17.6. SWOT analysis
  • 22.3.18. Detekt Biomedical LLC
    • 22.3.18.1. Overview
    • 22.3.18.2. Product Portfolio
    • 22.3.18.3. Sales Footprint
    • 22.3.18.4. Strategy Overview
    • 22.3.18.5. Key Financials
    • 22.3.18.6. SWOT analysis
  • 22.3.19. Guangzhou Wondfo Biotech Co., Ltd.
    • 22.3.19.1. Overview
    • 22.3.19.2. Product Portfolio
    • 22.3.19.3. Sales Footprint
    • 22.3.19.4. Strategy Overview
    • 22.3.19.5. Key Financials
    • 22.3.19.6. SWOT analysis
  • 22.3.20. Creative Diagnostics
    • 22.3.20.1. Overview
    • 22.3.20.2. Product Portfolio
    • 22.3.20.3. Sales Footprint
    • 22.3.20.4. Strategy Overview
    • 22.3.20.5. Key Financials
    • 22.3.20.6. SWOT analysis

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료